Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 4/20 | 0.52 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.52 |
| ▸ | NPY1R | P25929 | 3/20 | 0.52 |
| ▸ | NPY2R | P49146 | 1/20 | 0.52 |
| ▸ | APC | P25054 | 3/20 | 0.50 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.49 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.49 |
| ▸ | CCKBR | P32239 | 1/20 | 0.48 |
| ▸ | TFPI | P10646 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 2/20 | 0.46 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26428962 | 0.92 | GRIA1 (0.54) | NPY4RNPY5RNPY1RNPY2RGRIA1 | |
| SCHEMBL26428992 | 0.84 | NPY4R (0.49) | NPY4RNPY5RNPY1RNPY2ROPRD1 | |
| SCHEMBL14005788 | 0.81 | BACE1 (0.59) | APCOPRD1PTPN1CCKBRTFPI | |
| SCHEMBL26080388 | 0.81 | GRIA1 (0.61) | NPY4RNPY5RNPY1RNPY2RGRIA1 | |
| SCHEMBL13209217 | 0.80 | IL23R (0.61) | TFPI | |
| SCHEMBL15186081 | 0.80 | GRIA1 (0.53) | NPY4RNPY5RNPY1RNPY2RPTPN1 | |
| SCHEMBL13254722 | 0.79 | IL23R (0.54) | OPRD1OPRM1OPRK1TFPI | |
| SCHEMBL30061253 | 0.79 | F2 (0.54) | OPRD1OPRM1OPRK1TFPI | |
| SCHEMBL14478103 | 0.79 | APC (0.60) | NPY4RNPY5RNPY1RNPY2RAPC | |
| SCHEMBL30863549 | 0.79 | GRIA1 (0.56) | NPY4RNPY5RNPY1RNPY2ROPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230127524-A1 | FILAMENTOUS NANOSTRUCTURES AND THEIR USE FOR TREATMENT OF PULMONARY DISEASE | NATIONAL SCIENCE FOUNDATION | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230127524-A1 | FILAMENTOUS NANOSTRUCTURES AND THEIR USE FOR TREATMENT OF PULMONARY DISEASE | MFAP1, DIAPH1, SEPTIN7 | NPY4R 1036/4885NPY5R 447/4885NPY1R 429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.